TerraBioGen Appoints Chief Technical Officer

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS
AGENCIES


TerraBioGen Technologies Inc. (TSX VENTURE:TBG), developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, is pleased to announce the
appointment of S.R. Prabhu as Chief Technical Officer of the company.


Prabhu has been employed with TerraBioGen as its' Senior Research
Scientist/Research Manager for the past 8 years and has been the key individual
in developing value in the Company's proprietary EATAD process and resulting
soil fertility products. After completing graduate studies in Agricultural
Microbiology from Tamil Nadu Agricultural University, India, Prabhu served the
Agricultural Research Service (ARS) of the Indian Council of Agricultural
Research for over a decade before joining TerraBioGen. To his credit, Prabhu has
many widely adopted bio-resource technologies within the agricultural community.
His primary responsibility with TerraBioGen includes the on-going optimization
of the TerraBioGen EATAD process and the further development of innovative
biological soil fertility products.


Blair Heffelfinger, President and CEO of the company stated that "this
appointment reflects the important contributions Prabhu has been making for the
company. As our biological research department continues to expand in the area
of agricultural bioscience, Prabhu's role will continue to grow."


About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a world wide marketing capability to ensure market acceptance of its
products.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward looking
statements. Forward looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024